BC
Burney Company’s Corcept Therapeutics CORT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.4M | Sell |
250,146
-16,251
| -6% | -$1.19M | 0.62% | 40 |
|
2025
Q1 | $30.4M | Sell |
266,397
-207,424
| -44% | -$23.7M | 1.11% | 14 |
|
2024
Q4 | $23.9M | Buy |
473,821
+39,657
| +9% | +$2M | 0.84% | 24 |
|
2024
Q3 | $20.1M | Buy |
434,164
+17,366
| +4% | +$804K | 0.71% | 30 |
|
2024
Q2 | $13.5M | Sell |
416,798
-14,840
| -3% | -$482K | 0.52% | 45 |
|
2024
Q1 | $10.9M | Buy |
431,638
+12,402
| +3% | +$312K | 0.41% | 62 |
|
2023
Q4 | $13.6M | Buy |
419,236
+17,973
| +4% | +$584K | 0.57% | 34 |
|
2023
Q3 | $10.9M | Buy |
401,263
+115,006
| +40% | +$3.13M | 0.51% | 49 |
|
2023
Q2 | $6.37M | Sell |
286,257
-612
| -0.2% | -$13.6K | 0.29% | 91 |
|
2023
Q1 | $6.21M | Sell |
286,869
-9,452
| -3% | -$205K | 0.31% | 91 |
|
2022
Q4 | $6.02M | Sell |
296,321
-94,959
| -24% | -$1.93M | 0.3% | 95 |
|
2022
Q3 | $10M | Buy |
391,280
+50,792
| +15% | +$1.3M | 0.55% | 46 |
|
2022
Q2 | $8.1M | Sell |
340,488
-9,492
| -3% | -$226K | 0.43% | 63 |
|
2022
Q1 | $7.88M | Sell |
349,980
-1,596
| -0.5% | -$35.9K | 0.36% | 80 |
|
2021
Q4 | $6.96M | Sell |
351,576
-31,600
| -8% | -$626K | 0.3% | 100 |
|
2021
Q3 | $7.54M | Sell |
383,176
-3,432
| -0.9% | -$67.5K | 0.35% | 84 |
|
2021
Q2 | $8.51M | Buy |
386,608
+8,781
| +2% | +$193K | 0.4% | 74 |
|
2021
Q1 | $8.99M | Buy |
377,827
+9,796
| +3% | +$233K | 0.44% | 67 |
|
2020
Q4 | $9.63M | Buy |
368,031
+21,573
| +6% | +$564K | 0.53% | 54 |
|
2020
Q3 | $6.03M | Buy |
346,458
+79,649
| +30% | +$1.39M | 0.37% | 79 |
|
2020
Q2 | $4.49M | Buy |
+266,809
| New | +$4.49M | 0.29% | 104 |
|